Robert T. Schooley
Robert "Chip" T. Schooley (born November 10, 1949) is an American infectious disease physician, who is the Vice Chair of Academic Affairs, Senior Director of International Initiatives, and Co-Director at the Center for Innovative Phage Applications and Therapeutics (IPATH), at the University of California San Diego School of Medicine. He is an expert in HIV and hepatitis C (HCV) infection and treatment, and in 2016, was the first physician to treat a patient in the United States with intravenous bacteriophage therapy for a systemic bacterial infection. Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Robert T. Schooley', query time: 0.03s
Refine Results
-
1
Cancer, more than a “COVID-19 co-morbidity” by Chinmay T. Jani, Chinmay T. Jani, Robert T. Schooley, Rana R. Mckay, Scott M. Lippman
Published 2023-03-01
Article -
2
-
3
-
4
Microbiological assessment reveals that Salmonella, Shigella and Campylobacter infections are widespread in HIV infected and uninfected patients with diarrhea in Mozambique. by Delfina Fernandes Hlashwayo, Emília Virgínia Noormahomed, Leonilde Bahule, Constance Benson, Robert T Schooley, Betuel Sigaúque, Kim E Barrett, Custódio Gabriel Bila
Published 2023-01-01
Article -
5
Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from Mozambique by Delfina F Hlashwayo, Emília V Noormahomed, Leonilde Bahule, Constance A Benson, Robert T Schooley, Betuel Sigaúque, Kim E Barrett, Custódio G Bila
Published 2023-04-01
Article -
6
Fostering Sustainable Biomedical Research Training in Mozambique: A Spin-Off of the Medical Education Partnership Initiative by Emília Virgínia Noormahomed, Sérgio Noormahomed, Delfina Hlashwayo, Emília Martins, Mamudo Ismail, Stephen W. Bickler, Jean Nachega, Manuel Mahoche, Kim E. Barrett, Constance A. Benson, Robert T. Schooley
Published 2022-08-01
Article -
7
Successful Treatment of <i>Staphylococcus aureus</i> Prosthetic Joint Infection with Bacteriophage Therapy by Claudia Ramirez-Sanchez, Francis Gonzales, Maureen Buckley, Biswajit Biswas, Matthew Henry, Michael V. Deschenes, Bri’Anna Horne, Joseph Fackler, Michael J. Brownstein, Robert T. Schooley, Saima Aslam
Published 2021-06-01
Article -
8
Whole-genome surveillance identifies markers of Plasmodium falciparum drug resistance and novel genomic regions under selection in Mozambique by Erin Coonahan, Hunter Gage, Daisy Chen, Emilia Virginia Noormahomed, Titos Paulo Buene, Irina Mendes de Sousa, Kevan Akrami, Lucia Chambal, Robert T. Schooley, Elizabeth A. Winzeler, Annie N. Cowell
Published 2023-10-01
Article -
9
Comparative metabolomics revealed key pathways associated with the synergistic killing of multidrug-resistant Klebsiella pneumoniae by a bacteriophage-polymyxin combination by Mei-Ling Han, Sue C. Nang, Yu-Wei Lin, Yan Zhu, Heidi H. Yu, Hasini Wickremasinghe, Christopher K. Barlow, Darren J. Creek, Simon Crawford, Gauri Rao, Chongshan Dai, Jeremy J. Barr, Kim Chan, Robert Turner Schooley, Tony Velkov, Jian Li
Published 2022-01-01
Article -
10
Safety and microbiological activity of phage therapy in persons with cystic fibrosis colonized with Pseudomonas aeruginosa: study protocol for a phase 1b/2, multicenter, randomized... by Pranita D. Tamma, Maria Souli, Michael Billard, Joseph Campbell, Douglas Conrad, Damon W. Ellison, Beth Evans, Scott R. Evans, Kerryl E. Greenwood-Quaintance, Andrey A. Filippov, Holly S. Geres, Toshimitsu Hamasaki, Lauren Komarow, Mikeljon P. Nikolich, Thomas P. Lodise, Seema U. Nayak, Carmelle Norice-Tra, Robin Patel, David Pride, Janie Russell, Daria Van Tyne, Henry F. Chambers, Vance G. FowlerJr, Robert T. Schooley, for the Antibacterial Resistance Leadership Group
Published 2022-12-01
Article